2 recruiting, 1 completed. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Recruiting 2, Completed 1 |
Follow Incontinence, Urge: new trials by email Literature Review of Incontinence, Urge trials Research Report on Incontinence, Urge
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| TReating Incontinence for Underlying Mental and Physical Health Tolterodine Tartrate ER, Mirabegron, Placebo - Urinary Incontinence, Urge, Urinary Incontinence | Phase 4 | Recruiting | University of California, San Francisco | 270 | 2022-10-04 | 2026-03-06 |
| Post-procedural Pain Associated With 5 Versus 20 Intravesical Injections of Onabotulinumtoxin A OnabotulinumtoxinA 100 UNT - Urinary Bladder, Overactive, Incontinence, Urge | Phase 4 | Recruiting | University of South Florida | 60 | 2019-10-09 | 2020-11-05 |
| Higher Neural Changes Following Anticholinergic, Beta 3 Agonist, or Placebo in Patients With Overactive Bladder Anticholinergic, Beta-3 Agonists, Adrenergic, Functional magnetic resonance imaging (fMRI) - Overactive Bladder, Dementia | Phase 4 | Completed | Baylor Research Institute | 12 | 2019-08-05 | 2024-02-02 |
Urinary Bladder, Overactive (3) · Urinary Incontinence, Urge (3) · Urinary Incontinence (2) · Dementia (1) · Lower Urinary Tract Symptoms (1) · Nocturia (1)
Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Male Urogenital Diseases (3) · Pathological Conditions, Signs and Symptoms (3) · Signs and Symptoms (3) · Urinary Bladder Diseases (3) · Urination Disorders (3) · Urogenital Diseases (3) · Urologic Diseases (3) · Urological Manifestations (3) · Lower Urinary Tract Symptoms (2) · Brain Diseases (1) · Central Nervous System Diseases (1) · Mental Disorders (1) · Nervous System Diseases (1)
mirabegron (2) · Adrenergic beta-3 Receptor Agonists (1) · Botulinum Toxins, Type A (1) · Cholinergic Antagonists (1) · Magnetic Resonance Imaging (1) · Solifenacin Succinate (1) · Tolterodine Tartrate (1)
Baylor Research Institute (1) · University of California, San Francisco (1) · University of South Florida (1)
United States (3)
Alison Huang, MD, MAS, MPhil (1) · Eric S Chang, MD (1) · Jill Danford, MD (1) · Rachel High, DO (1) · Rose Khavari, MD (1)
PMID 35543540, PMID 37085880, PMID 37160401
R01AG075471 (1)